At the San Raffaele Scientific Institute (Milan, Italy) I serve as Director of Diabetes Research Institute, Director of Human Islet Transplantation Program (http://www.sanraffaele.org/ ENGhome/ research/ divisions_centers_institutes_research_programs/ ITP/ index.html). I also serve as Head of the Beta Cell Biology Unit (Diabetes Research Institute), and Director of Human Islet Processing Facility, and coordinator of European Consortium for Islet Transplantation that has been providing Human beta Cell Products for research and clinical applications at HSR, in Italy and across state barriers in Europe since 2000 (See European Consortium for Islet Transplantation, http://ecit.drisanraffaele.org/en/islet-transplatntation/index.html). I also serve as Professor in Endocrinology at University “Vita Salute San Raffaele” of Milan and as Honorary Visiting Professor at Vrije Universiteit of Brussel. My area of expertise is mainly focused on diabetes and pancreatology. In particular I have large experience about diabetes and pancreatic cancer. I have in the past studied the role of innate immunity in islet cell biology (especially in the human model of islet transplantation in type 1 diabetes recipient) and in pancreatic cancer biology (especially the role of chemokines and chemokine receptor system in inducing leukocytes infiltration). In addition, my research interests include beta cell replacement, immune tolerance induction strategies, dendritic cell biology, stem cells. I currently serve as section Editor of Cell Transplantation-the Regenerative Medicine Journal and of Current Diabetes Reports, as editorial board of Acta Dibetologia, as Councilor of the International Pancreas and Islet Transplantation Association (IPITA) of The Transplantation Society (TTS) and as member of the European Pancreas and Islet Transplantation Association (EPITA) committee of European Society for Organ Transplantation (ESOT).
Publication activity (July 2017)
Lorenzo Piemonti authored a total of 158 original articles published in peer-reviewed journals surveyed in PubMed. h-index (06/07/2017): 38 Web of Science; 41 Scopus; 47 Google Scholar. Considering the period 2001-2017 Lorenzo Piemonti authored a total of 135 original
14:15 - 15:45
|State-of-the-Art Session — Beta-Cell Replacement Therapy: Current Outcomes and Future Landscape||Future Landscape: Defining a successful outcome using stem cells as a source of insulin producing cells||TBD|
13:30 - 14:30
|Lunch and Learn — Lunch and Learn 3||Islet auto-transplantation for non-pancreatitis indications||TBD|
|Scientific Program Committee: Pancreas and Islet||Co-Chair|